Applied Clinical Trials: CRO News
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
CRO News - Applied Clinical Trials
Click here to search FindPharma.com FindPharma
Most Popular: October Issue // Quality Control and Assurance in Clinical Research // Key Factors in CRO Selection
In this issue
Quintiles, AZ’s Sole Provider
FIPNetsToday
Medpace’s Oncology Foothold
New Trials Web Site
Predicting Enrollment
Key Topic Updates

Partnerships in Clinical Trials—Asia Pacific
December 1-3
Singapore

Project Management for Pharmaceutical Professionals
February 2-3
London, UK

Project Management Phase I-II
March 22-23
Malvern, PA


LCGC Europe - News Update
What’s New with Regulatory and Obesity Drugs, a Podcast Interview with Medpace’s Executive Director of Regulatory Affairs David Orloff, MD
Using Comparative Effectiveness Data: a Webcast
Boss of Scottish CRO Reveals Trade Secrets

Contact Us
Contact Marissa Shapiro, assistant editor.

Learn about direct mail opportunities.

Learn about advertising opportunities.

Learn about reprints of Applied Clinical Trials.

Learn about classifieds in Applied Clinical Trials.

November 18, 2009
Quintiles and AZ Team Up
In yet another example of a strategic partnering alliance, Quintiles’ recently announced clinical pharmacology alliance with AstraZeneca calls for the private CRO to take over the pharma’s operational responsibilities and hold sole provider status of these services in a standardized pricing model. More...
Fully Integrated Pharmaceutical Networks (FIPNets), Not Ready for Prime-Time
The landscape of sponsor-CRO relationships is gradually transitioning from traditional sponsor-vendor relationship to more integrated alliances. However, alliances still remain a relatively small percentage of a sponsor’s portfolio. A report from Ken Getz, Senior Research Fellow at Tufts CSDD and Applied Clinical Trials Clinical Insights Columnist, explores this. More...
Medpace Acquires Pharma Brains AG
On June 24, after being a private company for almost 10 years, Medidata Solutions priced its initial public offering (IPO) at $14 a share and began training on the NASDAQ under MDSO on June 25. Its second quarter 2009 results were announced on August 13 with largely positive news. More...
Quintiles Launches Trial Site
Clinicalresearch.com from Quintiles aims to bring patient-friendly and patient-centric clinical research trials information and data. More...
Enrollment Planning for Critical Path Studies
DecisionView offers this insight to the need for utilizing predictive analytics to successfully determine enrollment projections and plan accordingly. More...
Webcast
Quintiles
Rich opportunities for your clinical trials are emerging increasingly in non-traditional markets. But diverse regulatory requirements and varying timelines may be keeping you from exploring opportunities in these regions. How can you realize the potential recruitment advantages, cost-savings and efficiencies? Watch our webcast to hear five Quintiles experts share insights to help you navigate the global regulatory landscape — and find your new development edge.
» Watch our webcast
Key Topic Updates
Global Trials
CROs Face Change in Italy
EDC Acceptance in Japan
Conducting Trials in Croatia
South Africa Today
Spotlight Falls On India
Regulatory
Comprehensive Guide for Generic Drug Trials
Project Management
Financial Simulation Modeling in Clinical Trials
Community
Executive VP of Phase IV Development Named by PharmaNet
INC Research Hires VP of Regulatory Affairs & Strategic Drug Development
Kendle Appoints VP of Consulting

You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this,
click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.